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Abstract
Trauma is a significant problem across the globe with mortality more than 50%. Despite
the advancement of pre-hospital care to trauma patients, early resuscitation in the emer-
gency department, surgical interventions and intensive care monitoring mortality rate has
not improved yet. The higher rate of mortality in trauma patients is usually associated
with development of complications such as sepsis, septic shock, and MOF which may
occur due to hysterical immune inflammatory responses. Trauma patients who developed
these complications in the ICU have comparatively higher chances of mortality. Cytokines
are very important for host immune response against infections and play vital roles in the
regulation of innate and adaptive immunity. The slanted expression of cytokines due to
trauma may be involved in development of sepsis and related complications. The recently
published work from various studies suggested that slanted expression of cytokines
correlates with the variations in the promoter and structural regions of cytokine genes,
which may be responsible for inter-individual differences in susceptibility to sepsis.
Therefore, understanding the variations in cytokine genes and associated outcomes due
to trauma would possibly contribute to the event of latest genetically changed diagnostic
and therapeutic interventions that will improve the outcome in post-traumatic sepsis
patients.
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1. Introduction
Trauma remains a significant public health issue and is the fourth leading cause of death in
persons younger than 40 years [1, 2]. Worldwide, about 16,000 people die every day as a result
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of an injury (5.8 million deaths per year), and the projections for 2020 show that 8.4 million
deaths per year are expected [3].Consequently, injury will be the second most common cause
of disability adjusted years of life lost within the next 13 years (second only to cardiovascular
disease). Undoubtedly, the major burden of injury is increasingly occurring in the developing
world as it industrializes, adopts motorized transportation, and remains the major center for
armed conflict [4, 5]. Despite advancement in primary care to trauma patients, early resuscita-
tion in the emergency department, surgical interventions, and intensive care monitoring,
mortality rate has not improved yet. The higher rate of mortality to trauma patients is usually
associated with development of various complications such as sepsis, septic shock, and the
development of the multiple organ dysfunction syndrome (MODS) [6, 7]. The outcome of
trauma patients is not determined only by trauma but also by the impacts of immune-
inflammatory insult. The inflammatory response is crucial for the host defense against infec-
tions, but hysterical immune inflammatory responses are generated due to imbalance in the
production of inflammatory and anti-inflammatory cytokines which may lead to various
complications and consequently unfavorable outcomes [8, 9]. According to the biphasic model
of trauma etiology, dysregulations in the production of both inflammatory and anti-
inflammatory cytokines primarily lead to the sepsis-associated mortalities and outcomes [10,
11]. Posttraumatic sepsis which may cause hysterical immune inflammatory responses is one
of the leading sources of MODS in the ICU. Although there have been many advances in the
development of broad and narrow spectrum of antibiotics and thoughtful care, sepsis remains
a serious and deadly problem with high mortality rates across the globe. Therefore, prognostic
biomarkers to identify high-risk trauma patients in the early stages are immediately needed for
early detection and preventive care of sepsis. The management of severely injured and multi-
ple trauma patients who developed sepsis, septic shock, and MODS due to inflammatory
insults is challenging for the physician in the ICU. Trauma leads to imbalance in production
of pro-inflammatory and anti-inflammatory cytokines which may subsequently lead to the
SIRS, sepsis, septic shock, and MODS which are shown in Figure 1.
1.1. SIRS
Systemic inflammatory response syndrome (SIRS) is a term that was developed in an attempt
to describe the clinical manifestations that result from the systemic response to injury. The
criteria of SIRS are considered as having at least two of the following four clinical parameters
abnormal:
1. Temperature < 36C or > 38 C
2. Heart rate > 90 beats/min
3. Respiratory rate > 20 breaths/min or PaCO2 < 32 mm Hg
4. WBC count >12,000 cells/μL or < 4000 cells/μL, or > 10% immature forms
1.2. Sepsis
Sepsis is a common, deadly, and often underappreciated disease process in emergency depart-
ments. In the intensive care unit, if patients have SIRS along with documented cultures reports
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positive is called sepsis. Sepsis results in physiologic alterations that occur at the capillary
endothelial level.
1.3. Severe sepsis
Sepsis accompanied by signs of failure of at least one organ. Cardiovascular failure is typically
manifested with hypotension, respiratory failure by hypoxemia, renal failure by oliguria, and
hematologic failure by coagulopathy.
1.4. Septic shock
Severe sepsis with organ hypoperfusion and hypotension that are poorly responsive to initial
fluid resuscitation.
2. Multiple organ failure (MOF)
Multiple organ failure is a clinical syndrome in which the functionality of several organs fails
subsequently or simultaneously (i.e., liver, lungs, kidneys, heart). Multiple organ failure after
Figure 1. This figure shows that trauma leads to the imbalanced cytokine production which may subsequently lead to the
sepsis, severe sepsis, septic shock, MODS, and at last death. This figure also shows the criteria which are used to define
the SIRS sepsis, severe sepsis, septic shock, and MODS.
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trauma has a multifactorial etiology, which can be divided in endogenous and exogenous
factors [12]. The endogenous factors, such as genetic predisposition, form the basis of the
patient’s susceptibility for the development of organ failure. Recent studies have shown that
genetic variations (e.g., TNF-α polymorphisms) are strongly associated with the development
of organ failure [13].The exogenous factors, such as injury itself (the “first hit” or “trauma
load”) and the resuscitation or surgical intervention (the “second hit” or “intervention load”),
play a crucial role in the development of organ failure. Organ damage and subsequent organ
failure are the result of dysfunctional immune system [11, 14].
3. Role of cytokines in development of sepsis-related complications
Cytokines are low molecular weight polypeptides, and pharmacologically active molecules
possess autocrine, paracrine, and juxtracrine effects [15]. These molecules are classified into
several classes (i.e., interleukins, interferons, colony-stimulating factors, tumor necrosis factors,
Figure 2. The outcome of trauma patients depends on induced inflammatory response due to trauma such as migration
of leukocytes, cellular activation, and effecter functions, which may subsequently depend on genetic background of
individuals.
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transforming growth factors, and chemokines), which are relevant to mediate the humoral and
cellular immunity to protect the host against pathogens [16]. Cytokines are produced by a
wide variety of lymphoid and nonlymphoid cells in the body, playing an important role in
many physiological responses against infections and injury. In addition, cytokines exert impor-
tant pleiotropic actions as cardinal effectors of injury [17]. They play vital roles in the regula-
tion of host immune response, and distorted expression of cytokines is proven to be involved
in development of complications such as sepsis, septic shock, and MODS. Many studies
suggested that the genetic background of individuals determines the impacts of immune
inflammatory response after trauma which may lead to differential cellular activations of
immune cells, leukocyte migrations, and effector functions (Figure 2). Previous research sug-
gests that the variations in the genes encoding cytokines are also involved in the inflammatory
responses and also responsible for inter-individual differences in susceptibility to sepsis and in
its severity [13, 18, 19]. Therefore, understanding the variations in cytokine genes and associ-
ated differences in response to trauma might contribute to the development of new genetically
modified diagnostic and therapeutic interventions that may improve outcome in posttraumatic
sepsis patients.
4. Role of cytokine gene polymorphism in sepsis
Cytokine gene polymorphism, therefore, is advocated as the underlying reason to distinguish
individual specific immune responses. The cytokine gene polymorphism studies may be
considered as powerful biomarkers for the identification of trauma patients who have higher
risk to develop sepsis complications in the ICU [20, 21]. Therefore, understanding the associa-
tions between genetic polymorphisms and sepsis or MODS may lead to the better understand-
ing of sepsis. Nowadays the significance of genetic variations [particularly single-nucleotide
polymorphisms (SNPs)] as key determinants of inter-individual variations in both inflamma-
tory responses and clinical outcome in trauma patients is advocated [13, 22]. Single-nucleotide
polymorphisms are the key factors to regulate the expressional variation of human genes and
found to be associated with the disease susceptibility and progression. To understand the
importance of cytokine gene polymorphism (CGP) while predicting the occurrence of sepsis,
the SNPs in the promoter, coding, and noncoding regions of 13 cytokine genes with 22 loci are
commonly used. Single-nucleotide polymorphisms of 13 cytokine genes including interleukin
IL-1-α (T/C-889), IL-1-β (-511 C/T, T/C + 3962), IL-1 RA (T/C mspal 1100), IL-4 RA (G/A + 1902),
IL-4(T/G-1098, T/C-590, T/C-33), IL-6 (G/C-174, G/A nt560), IL-10 (G/C-1082, C/T-819, C/A-
592), IL-12 (C/A-1188), γIFN (+874 A/T), TGF-β1(C/T codon 10, G/C codon 25), TNF α (G/A -
308, G/A-238), and IL-2(T/G-330 G/T + 166), to investigate the susceptibility towards sepsis in
trauma patients, are commonly used. All the cytokine genes and their polymorphic loci which
are commonly used to investigate the genetic basis of susceptibility towards disease are shown
in Table 1. Various studies also showed the associations of these SNPs in the development of
sepsis and outcomes. The polymorphic loci in the promoter region of TNF-α-308 and TNF-α-
238 have been reported by various studies and showed susceptibility and resistance between
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populations [23, 24]. These two polymorphisms are well recognized and associated with
susceptibility for tuberculosis, heart disease, and Graves’ disease [25–27]. The interleukin 6 is
an important cytokine and plays a very important role in the activation of T17 cells. The
polymorphisms in the promoter region of IL-6 (174 G/C) and structural region (+560) are
well characterized in various diseases. However, the polymorphism in the promoter regions
(174G/C) showed significant association with celiac disease, bowel syndrome, cancer, and
autoimmunity [28–31]. Interestingly, the polymorphism in the promoter region of IL-6
(174 G/C) influenced the immunopathogenesis of sepsis and associated with outcomes in
European population of trauma [32, 33]. We have also reported the association of IL-6 (174 G/
C) polymorphism and susceptibility of sepsis in the Indian trauma patients [34]. IL-10 is an
important anti-inflammatory cytokine and plays a very crucial role in the inflammation,
autoimmunity, and tolerance. Many studies suggested that elevated level of IL-10 activates
the transcription factor Fox P3 which may subsequently lead to the production T regulatory
cells. Polymorphism in the promoter regions of IL-10 gene 1082(G/A), 819(C/T), and  592
(C/A) is well established and showed significant association with various infectious diseases,
autoimmunity, cancer D, and diabetic retinopathy [35–37]. These IL-10 promoters, 1082(G/
A), 819(C/T), and  592(C/A) polymorphisms, are associated with resistance to sepsis in the
Caucasian population [38, 39]. Interleukin (IL-1) gene complex consists of IL-1α, IL-1β, IL-1R,
and IL-RA genes with five potent polymorphic loci in the structural and promoter regions [40].
These polymorphic loci are associated with susceptibility for sepsis in trauma patients of the
Chinese population [41, 42] and also associated with other diseases, such as cancer and
autoimmunity [43, 44]. In our study, we have reported the changes in alleles and genotype
frequency at the promoter region of IL-1β (511) gene. We have also reported the significant
association of this polymorphism with susceptibility for sepsis in Indian trauma patients. The
recently published work by Gupta et al., 2016, showed that polymorphisms in the structural
and promoter regions of TNF-α, IL-β, IL-6, and IL-10 are significantly associated with suscep-
tibility to sepsis and outcomes in trauma patients [34] (Figure 3).
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Table 1. Twenty-two single-nucleotide polymorphism in 13 cytokine genes including structural and coding regions.
Figure 3. This figure shows the cytokine genes and its polymorphic loci present in the structural and promoter regions
which are significantly involved in susceptibility for sepsis, septic shock, and death.
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5. Conclusion
The purpose of this chapter is to bring together currently available information of cytokine
gene polymorphisms in pro-inflammatory and anti-inflammatory cytokine genes in the devel-
opment of various complications such as sepsis, septic shock, and MODS in trauma patients.
Specific emphasis is placed on the polymorphism of those cytokines which potentially contrib-
uted to the development of these complications and correlates with unfavorable outcomes.
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